Using the American Joint Committee on Cancer staging system, we found that TLX1NB was expressed at higher levels in N2 stage COAD samples than in N0 (P < 0.05) or N1 (P < 0.05) stage samples (Figure 1(b)). Here, TLX1NB is linked to cancer.